Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
| Actual shortage: | 53 (11%) | |
| Anticipated shortage: | 21 (5%) | |
| Avoided shortage: | 9 (2%) | |
| Resolved: | 382 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-22 | 2020-02-07 | 99541 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-19 | 2020-03-24 | 106721 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-03-26 | 2020-04-08 | 109432 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144044 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-12 | 2024-03-02 | 144047 |
| BISOPROLOL | 5MG | TABLET | Resolved | 2020-03-26 | 2020-03-27 | 109422 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2019-02-11 | 2019-03-02 | 75262 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2020-03-26 | 2020-04-03 | 109442 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2023-11-22 | 2024-01-17 | 211081 |
| CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2024-02-26 | 2024-03-09 | 220663 |
| TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-06-10 | 2019-06-28 | 86053 |
| TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Resolved | 2019-05-06 | 2019-06-08 | 83138 |
| TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Resolved | 2019-11-21 | 2019-11-28 | 99486 |
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-08-02 | 2020-02-27 | 17941 |
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-08-02 | 2020-02-27 | 17945 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-08-02 | 2020-02-27 | 17949 |
| DILTIAZEM CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-08-02 | 2020-02-27 | 17952 |
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-02 | 2020-02-27 | 17955 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-02 | 2020-02-27 | 17958 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-08-02 | 2020-02-27 | 17961 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |